A Novel Data Augmentation Strategy for Robust Deep Learning Classification of Biomedical Time-Series Data: Application to ECG and EEG Analysis

Researchers propose a unified deep learning framework combining ResNet-based CNNs with attention mechanisms and novel data augmentation techniques for analyzing biomedical time-series signals like ECG and EEG. The approach achieves near-perfect accuracy (99.78-100%) on benchmark datasets while remaining lightweight enough for wearable deployment, addressing critical gaps in multi-signal analysis and class imbalance handling.

This research addresses a fundamental challenge in medical technology: the need for unified architectures capable of processing fundamentally different physiological signals with equal effectiveness. The proposed framework tackles two interconnected problems that have plagued biomedical AI development—signal heterogeneity and class imbalance—through an innovative time-domain data augmentation strategy that concatenates multiple augmented signal variants to enrich feature representations.

The breakthrough lies not merely in achieving exceptional accuracy metrics across three benchmark datasets, but in doing so while maintaining practical deployability constraints. At approximately 130 MB memory footprint and 10 millisecond processing time per sample, the architecture becomes viable for real-world clinical settings and consumer wearable devices. This efficiency-to-performance ratio represents significant progress beyond previous methods that often required substantial computational resources.

For the medical device and digital health industries, this work has tangible implications. Hospitals and clinics could deploy more reliable automated diagnostic systems for arrhythmia detection and seizure prediction without requiring premium infrastructure. Wearable manufacturers gain validated methodologies for integrating multi-sensor health monitoring into consumer products. The demonstrated robustness across ECG and EEG signals suggests the approach generalizes well, potentially extending to other physiological signals.

The integration of Focal Loss functions with advanced augmentation creates a reproducible framework that addresses the perennial problem of imbalanced medical datasets, where pathological conditions are naturally rarer than normal readings. Future research should explore how these techniques transfer to additional signal types and whether the framework maintains performance with real-world noise and device variability rather than controlled benchmark datasets.

• →Novel time-domain data augmentation strategy generates richer signal representations by concatenating multiple augmented variants of biomedical signals.
• →Unified deep learning architecture achieves 99.78-100% accuracy on ECG and EEG benchmark datasets, demonstrating robustness across different physiological signals.
• →Framework requires only ~130 MB memory and ~10 ms per sample processing time, enabling deployment on wearable and low-end medical devices.
• →Combination of Focal Loss and advanced augmentation effectively mitigates class imbalance problems common in biomedical datasets.
• →Architecture integrates ResNet-based CNN with attention mechanisms plus wavelet preprocessing, representing state-of-the-art approach to multi-signal biomedical analysis.